“It is gratifying to see that the FDA continues to facilitate technologies to address significant public health concerns,” said chair of the center, Dr. Michael L. Kochman, FACP, AGAF. “The AGA Center for GI Innovation and Technology’s obesity-focused meeting, held in conjunction with the FDA, and the annual AGA Tech Summits have helped inform the discussion surrounding the new and novel devices in the obesity and metabolism space.”
News
FDA approves ReShape intragastric balloon device
More Endoscopy, Pancreas, & Biliary Tract News
- AGA aims to increase awareness of exocrine pancreatic insufficiency
- FDA clears AI-assisted colonoscopy device
- Advances in pancreaticobiliary disease interventions: More options and better outcomes
- Mitochondrial DNA variant increases gallstone risk
- Fine-needle aspirate, biopsy found equivalent in randomized trial
- Safety alert for intragastric balloon systems
- Waiving screening copayments could cut colorectal cancer deaths
- AKI doubles risk of death for those with acute pancreatitis
Question 1 of 5